KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:开放图源暂不可得 入排置信度 0.85

Influence of different photobiomodulation protocols on the prevention of chemotherapy-induced dysgeusia in breast cancer patients treated with Doxorubicin-Cyclophosphamide: a phase III, randomized, triple-blinded non-inferiority clinical trial.

Cassia Emanuella Nóbrega Malta, Marcela Maria Fontes Borges, Giulianna Aparecida Vieira Barreto, Gabriella Julião Alves Costa, Lais Oliveira Castro Barroso, André Alves Crispim, José Fernando Bastos de Moura, Paulo Goberlânio de Barros Silva

Support Care Cancer 33(8) 692

PMID40658227
PMCID-
DOI10.1007/s00520-025-09756-4
发表日期2025-07-14
入排依据:This is a Phase III randomized trial in human breast cancer patients, but it evaluates photobiomodulation for preventing chemotherapy-induced dysgeusia (taste dysfunction) and quality-of-life outcomes. It does not report survival, progression, recurrence, death, hazard, or time-to-event efficacy outcomes required for Kaplan-Meier digitization.
PubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。
摘要

摘要

PURPOSE: To evaluate the non-inferiority of protocols with red (R) or infrared (IR) lasers alone when compared to the already established protocol of R + IR lasers. METHODS: This is a phase III, randomized, triple-blind, non-inferiority, placebo-controlled clinical trial consisting of three study groups (n = 60/group): one receiving R + IR lasers, one receiving only R-laser and IR-placebo and the third with IR-laser and R-placebo (2 J of R-laser and 3 J of IR-laser) in 23-points symmetrically distributed on the tongue. Clinicopathological, sociodemographic data, hematological tests, taste analysis, subjective taste scales (VAS, CTCAE, and STTA), Quality-of-life (OHIP-14), ECOG general health status, body mass index (BMI), CPOD, salivary flow, and other side effects were collected. Chi-square/Fisher's exact tests and Kruskal-Wallis/Dunn (intergroup-analysis) or Friedman/Dunn (intragroup-analysis) tests were used (Margin of non-inferiority: 2-tailed p < 0.05). RESULTS: In the R + IR group, the objective did not reduce significantly (p = 0.873), but in the R-group, there was a significant reduction of taste function (p = 0.020). VAS (p < 0.001), CTCAE (p < 0.001), STTA (p < 0.001), and OHIP-14 (p < 0.001) analysis in the IR-group was significantly worse than the R + IR group. The ECOG parameter showed an improvement in the R + IR group (20%) compared to the R (11.7%) or IR (6.7%) groups over the course of the CT cycles (p = 0.037). There was no difference in BMI (p = 0.251), but the R + IR group gained significantly more weight (p = 0.044) without an increase in the frequency of obesity (p = 0.850). Groups R (p < 0.001) and IR (p = 0.046), but not R + IR (p = 0.369), showed a reduction in salivary flow. CONCLUSION: Protocols R or IR proved to be inferior to the R + IR laser photobiomodulation protocol. TRIAL REGISTRATION: Brazilian Clinical Trials Registry ( www.ensaiosclinicos.gov.br ). APPROVAL NUMBER: RBR-9 × 5zrgm. DATE OF REGISTRATION: 12/07/2023.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。